Top Markets
#1 MowCat MowCat +48.96%
#2 Bermuda Shorts Bermuda Shorts +24.00%
#3 Velvet Velvet +22.97%
#4 Fake World Assets Fake World Assets +20.94%
#5 Quack AI Quack AI +19.20%
#6 Perle Perle +18.21%
#7 Block Street Block Street +18.19%
#8 Derive Derive +15.58%
#9 龙虾 (Lobster) 龙虾 (Lobster) +13.48%
#10 DUSK Network DUSK Network +12.02%
Coin of the day
MowCat MowCat
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
GeneTether Therapeutics Inc. GeneTether Therapeutics Inc.

GeneTether Therapeutics Inc.

GTTX
Clasificación en acciones #34710
GeneTether Therapeutics Inc. (GTTX.CN) is a biotechnology firm specializing in... GeneTether Therapeutics Inc. (GTTX.CN) is a biotechnology firm specializing in genetic medicines. Its primary focus is the advancement of gene-editing therapies, aiming to significantly boost the effectiveness of current genomic modification techniques. The company's pipeline is dedicated to engineering genetic treatments for individuals suffering from rare, single-gene disorders affecting the kidneys and skin. Established in 2018, GeneTether Therapeutics Inc. is headquartered in Kelowna, Canada.
Precio por acción
$0.10409799
Última sincronización: 2025-02-03
Capitalización bursátil
$5.07M
Cambio (1 día)
16.43%
Cambio (1 año)
0.00%
País
CA
Comercio GeneTether Therapeutics Inc. (GTTX)

Categoría

Healthcare
Ratio P/S de GeneTether Therapeutics Inc. (GTTX)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de GeneTether Therapeutics Inc., el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de GeneTether Therapeutics Inc. desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.74 -
BE